Montelukast 4 Mg Chewable Tablets
Out of date information, search anotherPACKAGE LEAFLET: INFORMATION FOR THE USER
MONTELUKAST
4mg chewable tablets For children from 2 to 5 years
Read all of this leaflet carefully before your child starts taking this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for your child only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as your child’s.
- If your child gets any side effects, talk to your doctor or pharmacist. This includes
any possible side effects not listed in this leaflet. See section 4._
What is in this leaflet:
1. What montelukast 4mg is and what it is used for
2. What you need to know before you take montelukast 4mg
3. How to take montelukast 4mg
4. Possible side effects
5. How to store montelukast 4mg
6. Contents of the pack and other information
1. What Montelukast 4mg is and what it is used for
The active substance in Montelukast 4mg is montelukast, which is a leukotriene receptor antagonist that blocks substances called leukotrienes.
Leukotrienes cause narrowing and swelling of airways in the lungs. By blocking leukotrienes, montelukast improves asthma symptoms and helps control asthma.
Your doctor has prescribed montelukast to treat your child’s asthma, preventing asthma symptoms during the day and night.
• Montelukast is used for the treatment of 2 to 5 year old patients who are not adequately controlled on their medication and need additional therapy
• Montelukast may also be used as an alternative treatment to inhaled corticosteroids for 2 to 5 year old patients who have not recently taken oral corticosteroids for their asthma and have shown that they are unable to use inhaled corticosteroids.
• Montelukast also helps prevent the narrowing of airways triggered by exercise for patients 2 years of age and older.
Your doctor will determine how montelukast should be used depending on the symptoms and severity of your child's asthma.
What is asthma?
Asthma is a long-term disease, which includes:
• difficulty breathing because of narrowed airways. This narrowing of airways worsens and improves in response to various conditions.
• sensitive airways that react to many things, such as cigarette smoke, pollen, cold air, or exercise.
• swelling (inflammation) in the lining of the airways.
Symptoms of asthma include: coughing, wheezing, and chest tightness.
Tell your doctor about any medical problems or allergies your child has now or has had.
Do not give montelukast to your child if he/she is allergic to montelukast (the active substance) or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
• If your child’s asthma or breathing gets worse, tell your doctor immediately.
• Montelukast is not intended for the treatment of acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you or your child.
Always have your child’s inhaled rescue medicine, for asthma attacks, with you.
• It is important that your child takes all asthma medications prescribed by your doctor. Montelukast should not be used instead of other asthma medications your doctor has prescribed for your child.
• Any patient on anti-asthma medicines should be aware that if he/she develops a combination of symptoms such as flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms, and/or rash, you should consult your doctor.
• Your child should not take aspirin (acetyl-salicyclic acid) or anti-inflammatory medicines (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they make his/her asthma worse.
Use in children
For children 2 to 5 years old, Montelukast 4mg chewable tablets are available.
For children 6 to 14 years old, Montelukast 5mg chewable tablets are available.
Other medicines and montelukast
Some medicines may affect how montelukast works, or montelukast may affect how your child’s other medicines work.
Tell your doctor or pharmacist if your child is taking, has recently taken or might take any other medicines.
Tell your doctor if your child is taking the following medicines before starting montelukast:
• phenobarbital (used for treatment of epilepsy)
• phenytoin (used for treatment of epilepsy)
• rifampicin (used to treat tuberculosis and some other infections)
• gemfibrozil (used for treatment of high lipid levels in plasma)
Montelukast with food, drink and alcohol
Montelukast 4mg chewable tablets should not be taken immediately with food, it should be taken 1 hour before or 2 hours after food.
Pregnancy, breast-feeding and fertility
Women who are pregnant, think they may be pregnant or planning to have a baby, should ask their doctor or pharmacist for advice before taking this medicine . Your doctor will assess whether you can take montelukast during this time.
It is not known if montelukast appears in breast milk. Women who are breast-feeding or intend to breast-feed, should ask their doctor or pharmacist for advice before taking this medicine.
Driving and using machines
This subsection is not applicable for the montelukast 4mg chewable tablets since they are intended for use in children 2 to 5 years of age; however the following information is relevant to the active ingredient, montelukast.
Montelukast is not expected to affect the ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with montelukast may affect some patients’ ability to drive or operate machinery.
Montelukast chewable tablets contain aspartame, a source of phenylalanine.
May be harmful for people with phenylketonuria (a rare hereditary disorder of metabolism).
3. How to take Montelukast 4mg
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
This medicine is to be given to a child under adult supervision.
The recommended dose is:
Children aged between 2 and 5 years: one Montelukast 4mg chewable tablet once daily. Tablet should be taken in the evening at least 1 hour before or 2 hours after a meal.
If your child takes more montelukast than he/she should
If your child has accidentally taken too much, or if someone else has taken your medicine by mistake, contact your doctor immediately.
There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.
If you forget to give montelukast to your child
Try to give montelukast as prescribed. However, if your child misses a dose, just resume the usual schedule of one tablet once daily.
Do not give a double dose to make up for a forgotten dose.
If your child stops taking montelukastMontelukast can treat your child’s asthma only if your child continues taking it.
It is important for your child to continue taking montelukast for as long as your doctor prescribes. It will help control your child’s asthma. It should be taken even when your child has no symptoms or has an acute asthma attack.
If you have any further questions on the use of this product, ask your child’s doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking montelukast and see a doctor or go to a hospital straight away if:
• You get swelling of the hands, feet, ankles, face, lips or throat which may cause difficulty in swallowing or breathing. You could also notice an itchy, lumpy rash (hives) or nettle rash (urticaria). This may mean you are having an allergic reaction to montelukast.
In clinical studies with montelukast 4mg chewable tablets, the most commonly reported side effects (affecting up to 1 in 10 paediatric patients treated) were stomach ache and thirst.
Additionally, while the medicine has been on the market, the following have been reported:
Very common (may affect more than 1 in 10 people)
Infection of the nose and throat.
Common (may affect up to 1 in 10 people)
Diarrhoea, feeling sick (nausea), being sick (vomiting), increased liver enzyme levels, rash, fever.
Uncommon (may affect up to 1 in 100 people)
Allergic reactions (including rash, swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing), abnormal dreams (e.g. nightmares), difficulty in sleeping (insomnia), sleepwalking, irritability, hostility, feeling anxious, restlessness, agitation including aggressive behaviour, depression, dizziness, drowsiness, paraesthesia (pins and needles/numbness), seizures, nosebleed, dry mouth, indigestion, bruising, nettle rash, itching, painful joints, muscle pain, muscle spasms, fatigue, general feeling of being unwell, swelling (oedema).
Rare (may affect up to 1 in 1,000 people)
Increased tendency to bleed, shaking (tremor), feeling your heartbeat, rapid swelling of the skin tissue (angioedema).
Very rare (may affect up to 1 in 10,000 people)
Hepatic problems (liver eosinophilic infiltration), hallucinations, disorientation, suicidal thinking and actions, inflammation of the liver (hepatitis), tender red lumps under the skin most commonly on your shins (erythema nodosum), severe skin reactions (erythema mutiforme).
In asthmatic patients treated with montelukast, very rare cases of a combination of symptoms, such as flu-like illness, pins and needles or numbness of arms and legs, worsening of lung symptoms and/or rash (Churg-Strauss syndrome), have been reported. You must tell your doctor right away if your child gets one or more of these symptoms.
Reporting side effects
If you get any side-effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Also you can help to make sure that medicines remain as safe as possible by reporting any unwanted side effects via the internet at www.mhra.gov.uk/yellowcard. Alternatively you can call Freephone 0808 100 3352 (available from 10 a.m. to 2 p.m. Mondays to Fridays) or fill in a paper form available from your local pharmacy.
5. How to store Montelukast 4mg
Keep this medicine out of the sight and reach of children. Store in the original package, in order to protect from light.
Do not use this medicine after the expiry date which is stated on the blister and outer package (EXP). The expiry date refers to the last day of that month.
Do not use this medicine if you notice any visible sign of deterioration (change of colour, etc.).
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What montelukast contains
The active substance is: montelukast (as montelukast sodium).
One chewable tablet contains montelukast sodium, which is equivalent to 4mg monte-lukast.
The other ingredients are: microcrystalline cellulose, mannitol, crospovidone type B, red iron oxide (E172), hydroxypropylcellulose, disodium edetate, cherry flavour, aspartame (E951), talc, magnesium stearate.
What montelukast looks like and contents of the pack
Montelukast 4mg chewable tablets are pink, oval, biconvex tablets with "M4" engraved on one side.
Montelukast is available in blister packs of 10, 20, 28, 50 and 100 tablets and bottles of 10, 20, 28, 50 and 100 tablets
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Winthrop Pharmaceuticals,
PO Box 611,
Guildford,
Surrey,
GU1 4YS, UK
or
Zentiva,
One Onslow Street,
Guildford,
Surrey,
GU1 4YS, UK
Manufacturer
Takeda Pharma Sp.z.o.o. Ul.Ksiesta Lowickiego 12 99-420 Lyszkowice Poland
or
Zentiva S.A.,
50, Theodor Pallady Blvd., 032266, Bucharest, Romania
or
HBM Pharma s.r.o. Sklabinska 30 036 80 Martin Slovak Republic
This leaflet was last revised in May 2013.
‘Winthrop’ is a registered trademark. © 2013 Winthrop Pharmaceuticals. or
‘Zentiva’ is a registered trademark. © 2013 Zentiva.